Outcome measures for multiple sclerosis

Abstract Background: This review determined the most commonly used, and reliable, measures for assessing clinical outcomes for multiple sclerosis (MS). Objectives: It was anticipated that this would facilitate the development of a common set of metrics, and aid reaching a consensus regarding the outcome measures that are typically used in the field of MS clinical research. Major findings: A thorough literature review of clinical outcome measures for MS produced 166 measures that have been used in this context. This list was then refined by discussion with a panel of consultant neurologists, which reduced the list to 23 commonly employed tools. This shortlist was then further refined through surveying 41 centres for MS treatment, which reduced the shortlist to 16 measures. The properties of these scales, in terms of their symptom/function domains, their specificity for MS, their administration characteristics, and their reliability and validity for MS, are all discussed. Conclusions: Conclusions regarding the development of potential sets of assessment measures for MS, which encompass broad symptom/function domains, and which are sensitive to the practical requirements of administration within clinical contexts, are explored.

[1]  G Luccichenti,et al.  Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing–remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study , 2009, Multiple sclerosis.

[2]  J. Fischer,et al.  Intrarater and interrater reliability of the MS functional composite outcome measure , 2000, Neurology.

[3]  María I. Comeche,et al.  Psychological Assessment via the Internet: A Reliability and Validity Study of Online (vs Paper-and-Pencil) Versions of the General Health Questionnaire-28 (GHQ-28) and the Symptoms Check-List-90-Revised (SCL-90-R) , 2007, Journal of medical Internet research.

[4]  J. Fischer,et al.  Use of the multiple sclerosis functional composite as an outcome measure in a phase 3 clinical trial. , 2001, Archives of neurology.

[5]  A. Petruckevitch,et al.  The Functional Independence Measure: a comparative validity and reliability study. , 1995, Disability and rehabilitation.

[6]  P. Panegyres,et al.  Cognitive impairment in multiple sclerosis: Evidence-based analysis and recommendations , 2007, Journal of Clinical Neuroscience.

[7]  T. Marrie,et al.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[8]  A. Giordano,et al.  Responsiveness of patient reported outcome measures in multiple sclerosis relapses: the REMS study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[9]  G. W. Ellison,et al.  A health-related quality of life measure for multiple sclerosis , 1995, Quality of Life Research.

[10]  H. Lassmann,et al.  Progressive multiple sclerosis , 2009, Seminars in Immunopathology.

[11]  N. Lincoln,et al.  Assessment of emotional problems in people with multiple sclerosis , 2001, Clinical rehabilitation.

[12]  A. Thompson,et al.  Talking the talk on walking the walk , 2006, Journal of Neurology.

[13]  G. Cutter,et al.  Persistent pain and uncomfortable sensations in persons with multiple sclerosis , 2007, Pain.

[14]  Deborah M. Miller,et al.  Clinical significance of the multiple sclerosis functional composite: relationship to patient-reported quality of life. , 2000, Archives of neurology.

[15]  V de Groot,et al.  The usefulness of evaluative outcome measures in patients with multiple sclerosis. , 2006, Brain : a journal of neurology.

[16]  J. Holmes,et al.  Should the Mini Mental State Examination be used to monitor dementia treatments? , 1999, The Lancet.

[17]  R. Rudick,et al.  Challenges to clinical trials in multiple sclerosis: outcome measures in the era of disease-modifying drugs. , 2011, Current opinion in neurology.

[18]  R. Motl,et al.  Possible clinical outcome measures for clinical trials in patients with multiple sclerosis , 2010, Therapeutic advances in neurological disorders.

[19]  T. Pekmezović,et al.  MSQoL-54 predicts change in fatigue after inpatient rehabilitation for people with multiple sclerosis , 2013, Disability and rehabilitation.

[20]  H Rodgers,et al.  A review of the properties and limitations of the Ashworth and modified Ashworth Scales as measures of spasticity , 1999, Clinical rehabilitation.

[21]  Jeffrey A Cohen,et al.  Disability outcome measures in multiple sclerosis clinical trials: current status and future prospects , 2012, The Lancet Neurology.

[22]  Getting the measure of multiple sclerosis , 2009, The Lancet Neurology.

[23]  V. Mathiowetz,et al.  Effects of an energy conservation course on fatigue impact for persons with progressive multiple sclerosis. , 2003, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[24]  Richard W. Bohannon,et al.  Interrater reliability of a modified Ashworth scale of muscle spasticity. , 1987, Physical therapy.

[25]  Shohreh Jalaie,et al.  Ashworth Scales are unreliable for the assessment of muscle spasticity , 2006, Physiotherapy theory and practice.

[26]  Robert W Motl,et al.  Physical activity and quality of life in multiple sclerosis: Intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support , 2009, Psychology, health & medicine.

[27]  Lynne Turner-Stokes,et al.  The UK FIM+FAM: development and evaluation , 1999 .

[28]  A F Long,et al.  The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosis , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[29]  Reinhard Hohlfeld,et al.  Multiple Sclerosis: A Comprehensive Text , 2008 .

[30]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[31]  E. McAuley,et al.  Physical activity, self-efficacy, and health-related quality of life in persons with multiple sclerosis: analysis of associations between individual-level changes over one year , 2013, Quality of Life Research.

[32]  C. Polman,et al.  Outcome measurement in multiple sclerosis: detection of clinically relevant improvement , 2010, Multiple sclerosis.

[33]  A. Janssens,et al.  A nxiety and depression influence the relation between disability status and quality of life in multiple sclerosis , 2003, Multiple sclerosis.

[34]  L. Fratiglioni,et al.  Interrater reliability in assessing functional systems and disability on the Kurtzke scale in multiple sclerosis. , 1988, Archives of neurology.

[35]  P Lindgren,et al.  Costs and quality of life of patients with multiple sclerosis in Europe , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[36]  B. Sharrack,et al.  The Guy's Neurological Disability Scale (GNDS): a new disability measure for multiple sclerosis , 1999, Multiple sclerosis.

[37]  C. Wiles,et al.  Electromyography characterization of stretch responses in hemiparetic stroke patients and their relationship with the Modified Ashworth Scale , 2005, Clinical rehabilitation.

[38]  R. Hughes,et al.  Clinimetric properties of a walking scale in peripheral neuropathy , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  J. Fisk,et al.  The Impact of Fatigue on Patients with Multiple Sclerosis , 1994, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[40]  D. Bourdette,et al.  Inter‐ and intrarater scoring agreement using grades 1.0 to 3.5 of the Kurtzke Expanded Disability Status Scale (EDSS) , 1992, Neurology.

[41]  G. Kwakkel,et al.  Measuring fatigue in patients with multiple sclerosis: reproducibility, responsiveness and concurrent validity of three Dutch self-report questionnaires , 2010, Disability and rehabilitation.

[42]  Anthony Feinstein,et al.  Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients , 2009, Multiple sclerosis.

[43]  M. Massagli,et al.  The multiple sclerosis rating scale, revised (MSRS-R): Development, refinement, and psychometric validation using an online community , 2012, Health and Quality of Life Outcomes.

[44]  V. Mathiowetz.  Test-retest reliability and convergent validity of the Fatigue Impact Scale for persons with multiple sclerosis. , 2003, The American journal of occupational therapy : official publication of the American Occupational Therapy Association.

[45]  Richard A. Rudick,et al.  The Multiple Sclerosis Functional Composite , 2010, Neurology.

[46]  H. Kearney,et al.  The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical) , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[47]  T. Vollmer,et al.  Assessing Quality of Life in Patients with Multiple Sclerosis , 2010 .

[48]  A. Pietilä,et al.  Health-related quality of life-testing the reliability of the MSQOL-54 instrument among MS patients. , 2007, Scandinavian journal of caring sciences.

[49]  Toshiyuki Yamamoto,et al.  [Validation of the Japanese-translated version Multiple Sclerosis Quality of Life-54 instrument]. , 2004, Rinsho shinkeigaku = Clinical neurology.

[50]  F. Bethoux,et al.  Evaluating walking in patients with multiple sclerosis: which assessment tools are useful in clinical practice? , 2011, International journal of MS care.

[51]  D. Goldberg.  Identifying psychiatric illness among general medical patients. , 1985, British medical journal.

[52]  P. Jongen,et al.  Health-related quality of life in relapsing remitting multiple sclerosis patients during treatment with glatiramer acetate: a prospective, observational, international, multi-centre study , 2010, Health and quality of life outcomes.

[53]  E J Orav,et al.  Disease steps in multiple sclerosis: a longitudinal study comparing Disease Steps and EDSS to evaluate disease progression , 1999, Multiple sclerosis.

[54]  C Trenkwalder,et al.  Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters , 2002, Multiple sclerosis.

[55]  M. Amato,et al.  Clinical outcome measures in multiple sclerosis , 2007, Journal of the Neurological Sciences.

[56]  C. Poser,et al.  Diagnostic criteria for multiple sclerosis , 2001, Clinical Neurology and Neurosurgery.

[57]  R. Snaith,et al.  The Hospital Anxiety and Depression Scale , 1983 .

[58]  J. De Keyser,et al.  The impact of disabilities on quality of life in people with multiple sclerosis , 2008, Multiple sclerosis.

[59]  G Cutter,et al.  The Multiple Sclerosis Functional Composite: a new clinical outcome measure for multiple sclerosis trials , 2002, Multiple sclerosis.

[60]  D. Ford,et al.  Commentary on ‘Disability outcome measures in multiple sclerosis clinical trials’ , 2012, Multiple sclerosis.

[61]  A. Haghighi,et al.  Validity and reliability of the Persian version of the multiple sclerosis quality of life questionnaire. , 2007, Neurology India.

[62]  R. Benedict,et al.  Reliability and validity of neuropsychological screening and assessment strategies in MS , 2007, Journal of Neurology.

[63]  A. Iudice,et al.  Reliability, practice effects, and change indices for Rao’s brief repeatable battery , 2010, Multiple sclerosis.

[64]  E. Waubant,et al.  EDSS variability before randomization may limit treatment discovery in primary progressive MS , 2013, Multiple sclerosis.

[65]  J. Corboy,et al.  Effects of Vestibular Rehabilitation on Multiple Sclerosis–Related Fatigue and Upright Postural Control: A Randomized Controlled Trial , 2011, Physical Therapy.

[66]  L. Whitehead,et al.  The measurement of fatigue in chronic illness: a systematic review of unidimensional and multidimensional fatigue measures. , 2009, Journal of pain and symptom management.

[67]  D. Goodkin,et al.  Screening for cognitive impairment in multiple sclerosis. An evaluation of the Mini-Mental State Examination. , 1990, Archives of neurology.

[68]  E. McAuley,et al.  Longitudinal measurement invariance of the Multiple Sclerosis Walking Scale-12 , 2011, Journal of the Neurological Sciences.

[69]  G. Ebers,et al.  Commentary: Outcome measures were flawed , 2010, BMJ : British Medical Journal.

[70]  P Sandercock,et al.  Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. United Kingdom Collaborators in the International Stroke Trial. , 1998, Stroke.

[71]  W. Taylor,et al.  Self-Valuation and Societal Valuations of Health State Differ With Disease Severity in Chronic and Disabling Conditions , 2004, Medical care.

[72]  A. Tennant,et al.  Developing a disease-specific quality of life measure for people with multiple sclerosis , 2001, Clinical rehabilitation.

[73]  K. Honkalampi,et al.  Is the beck depression inventory suitable for screening major depression in different phases of the disease? , 2004, Nordic journal of psychiatry.

[74]  D. Wade,et al.  The Guy's Neurological Disability Scale in patients with multiple sclerosis: a clinical evaluation of its reliability and validity , 2002, Clinical rehabilitation.

[75]  J S Rietman,et al.  Stop using the Ashworth Scale for the assessment of spasticity , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[76]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[77]  F Barkhof,et al.  MS Functional Composite , 2000, Neurology.

[78]  J. Ormel,et al.  Concurrent validity of GHQ-28 and PSE as measures of change , 1989, Psychological Medicine.

[79]  T. Kohlmann,et al.  International development of the Unidimensional Fatigue Impact Scale (U-FIS). , 2010, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[80]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[81]  P. Martinková,et al.  Assessment set for evaluation of clinical outcomes in multiple sclerosis: psychometric properties , 2012, Patient related outcome measures.

[82]  A. Thompson,et al.  Clinical appropriateness: a key factor in outcome measure selection: the 36 item short form health survey in multiple sclerosis , 2000, Journal of neurology, neurosurgery, and psychiatry.

[83]  X. Montalban,et al.  Responsiveness and predictive value of EDSS and MSFC in primary progressive MS , 2008, Neurology.

[84]  N. Schutte,et al.  Direct and indirect relationships between emotional intelligence and subjective fatigue in university students. , 2006, Journal of psychosomatic research.

[85]  R. Kalb.  The emotional and psychological impact of multiple sclerosis relapses , 2007, Journal of the Neurological Sciences.

[86]  M. Versteegh,et al.  Condition-specific preference-based measures: benefit or burden? , 2012, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[87]  C. Granger,et al.  The functional independence measure: a new tool for rehabilitation. , 1987, Advances in clinical rehabilitation.

[88]  R. Hays,et al.  Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis. , 1997, Journal of clinical epidemiology.

[89]  C. Chew‐Graham,et al.  Case identification of depression in patients with chronic physical health problems: a diagnostic accuracy meta-analysis of 113 studies. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[90]  J. Ormel,et al.  A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects , 1997, Psychological Medicine.

[91]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[92]  W Z Rymer,et al.  Objective quantification of spastic hypertonia: correlation with clinical findings. , 1992, Archives of physical medicine and rehabilitation.

[93]  S. Marino,et al.  The clinical use of quality-of-life scales in neurological disorders , 2013, Acta Neuropsychiatrica.

[94]  Reliability and Validity of the Adult Alpha Functional Independence Measure Instrument in England , 2010, The Journal of neuroscience nursing : journal of the American Association of Neuroscience Nurses.

[95]  A J Thompson,et al.  Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). , 2006, Brain : a journal of neurology.

[96]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[97]  A J Thompson,et al.  Measuring change in disability after inpatient rehabilitation: comparison of the responsiveness of the Barthel Index and the Functional Independence Measure , 1999, Journal of neurology, neurosurgery, and psychiatry.

[98]  L. Strand,et al.  Psychometric properties of a Norwegian version of Multiple Sclerosis Impact Scale (MSIS‐29) , 2010, Acta neurologica Scandinavica.

[99]  C. Wolfson,et al.  The inter-rater reliability and construct validity of the Functional Independence Measure for multiple sclerosis subjects , 1994 .

[100]  D. Mohr,et al.  The Validity of Beck Depression Inventory and Hamilton Rating Scale for Depression Items in the Assessment of Depression Among Patients with Multiple Sclerosis , 2005, Journal of Behavioral Medicine.

[101]  A J Thompson,et al.  Measuring the impact of MS on walking ability , 2003, Neurology.

[102]  S. Hasson,et al.  Measurement of lower-limb muscle spasticity: intrarater reliability of Modified Modified Ashworth Scale. , 2011, Journal of rehabilitation research and development.

[103]  Robert W. Motl,et al.  Confirmation and extension of the validity of the Multiple Sclerosis Walking Scale-12 (MSWS-12) , 2008, Journal of the Neurological Sciences.

[104]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.

[105]  A Thompson,et al.  The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure. , 2001, Brain : a journal of neurology.

[106]  J. Paltamaa,et al.  Reliability of physical functioning measures in ambulatory subjects with MS. , 2005, Physiotherapy research international : the journal for researchers and clinicians in physical therapy.

[107]  C. Polman,et al.  Psychometric evaluation of the multiple sclerosis impact scale (MSIS-29) for proxy use , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[108]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[109]  A. Tennant,et al.  Rasch analysis of the Modified Fatigue Impact Scale (MFIS) in multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[110]  D. Knol,et al.  Factor structure of Guy’s Neurological Disability Scale in a sample of Dutch patients with multiple sclerosis , 2011, Multiple sclerosis.

[111]  B. Sharrack,et al.  The psychometric properties of clinical rating scales used in multiple sclerosis. , 1999, Brain : a journal of neurology.

[112]  F. Horak,et al.  Body-worn motion sensors detect balance and gait deficits in people with multiple sclerosis who have normal walking speed. , 2012, Gait & posture.

[113]  Y. Agid,et al.  Unilateral Thalamic Deep Brain Stimulation for Disabling Kinetic Tremor in Multiple Sclerosis , 2012, Neurosurgery.

[114]  C. Polman,et al.  Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability , 2004, Multiple sclerosis.

[115]  T. Chalder,et al.  A review of psychological correlates of adjustment in patients with multiple sclerosis. , 2009, Clinical psychology review.

[116]  Emilio Portaccio,et al.  Multiple sclerosis-related cognitive changes: A review of cross-sectional and longitudinal studies , 2006, Journal of the Neurological Sciences.

[117]  J. Holmes,et al.  What drives quality of life in multiple sclerosis? , 2004, QJM : monthly journal of the Association of Physicians.

[118]  E. McAuley,et al.  Multi-group measurement invariance of the multiple sclerosis walking scale-12? , 2012, Neurological research.

[119]  Simon Thompson,et al.  Sources of Discovery, Reasons for Registration, and Expectations of an Internet-Based Register for Multiple Sclerosis: Visualisations and Explorations of Word Uses and Contexts , 2012, Int. J. Heal. Inf. Syst. Informatics.

[120]  X. Montalban,et al.  Does the Modified Fatigue Impact Scale offer a more comprehensive assessment of fatigue in MS? , 2005, Multiple sclerosis.

[121]  L. Paul,et al.  The effects of a 12-week leisure centre-based, group exercise intervention for people moderately affected with multiple sclerosis: a randomized controlled pilot study , 2012, Clinical rehabilitation.

[122]  AJ Thompson,et al.  Progression on the Multiple Sclerosis Functional Composite in multiple sclerosis: what is the optimal cut-off for the three components? , 2010, Multiple sclerosis.

[123]  F. Guillemin,et al.  Fatigue in multiple sclerosis is related to disability, depression and quality of life , 2006, Journal of the Neurological Sciences.

[124]  C. Lederer,et al.  Disability as an outcome in MS clinical trials , 2008, Neurology.

[125]  A. Tennant,et al.  Rasch analysis of the Beck Depression Inventory-II in a neurological rehabilitation sample , 2009, Disability and rehabilitation.

[126]  A. John,et al.  A Large-Scale Study of Anxiety and Depression in People with Multiple Sclerosis: A Survey via the Web Portal of the UK MS Register , 2012, PloS one.

[127]  Robert W Motl,et al.  Further validation of multiple sclerosis walking scale-12 scores based on spatiotemporal gait parameters. , 2013, Archives of physical medicine and rehabilitation.

[128]  J. DeLuca,et al.  Cognitive impairment in multiple sclerosis , 2008, The Lancet Neurology.

[129]  D. Molloy,et al.  Reliability of a Standardized Mini-Mental State Examination compared with the traditional Mini-Mental State Examination. , 1991, The American journal of psychiatry.

[130]  Jared M. Bruce,et al.  Treatment adherence in multiple sclerosis: association with emotional status, personality, and cognition , 2010, Journal of Behavioral Medicine.

[131]  C. Polman,et al.  A health‐related quality of life questionnaire for multiple sclerosis Patients , 1999, Acta neurologica Scandinavica.

[132]  G. Devins,et al.  Emotional impact of multiple sclerosis: recent findings and suggestions for future research. , 1987, Psychological bulletin.

[133]  Y. Ben-Shlomo,et al.  Validity of patient-derived disability and clinical data in multiple sclerosis , 2010, Multiple sclerosis.

[134]  J. L. Taylor,et al.  Assessing Depressive Symptoms in Multiple Sclerosis: Is It Necessary to Omit Items from the Original Beck Depression Inventory? , 1999, Journal of Behavioral Medicine.

[135]  A. Thompson,et al.  Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples , 2002, Journal of neurology, neurosurgery, and psychiatry.

[136]  B. Ashworth.  PRELIMINARY TRIAL OF CARISOPRODOL IN MULTIPLE SCLEROSIS. , 1964, The Practitioner.

[137]  L. Kappos,et al.  Reconsidering clinical outcomes in Multiple Sclerosis: Relapses, impairment, disability and beyond , 2008, Journal of the Neurological Sciences.

[138]  R. Knobler,et al.  The sensitivity of the Mini-Mental State Exam in the white matter dementia of multiple sclerosis. , 1992, Journal of clinical psychology.

[139]  R. Schall,et al.  Telephone and in-person proxy agreement between stroke patients and caregivers for the functional independence measure. , 1996, American journal of physical medicine & rehabilitation.

[140]  R. Dworkin,et al.  Pain associated with multiple sclerosis: Systematic review and proposed classification , 2008, PAIN®.

[141]  P. Scherer.  Cognitive screening in multiple sclerosis , 2007, Journal of Neurology.

[142]  Julián Benito-León,et al.  Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing , 2005, The Lancet Neurology.

[143]  M. Banks.  Validation of the General Health Questionnaire in a young community sample , 1983, Psychological Medicine.

[144]  C. Polman,et al.  Disease progression in multiple sclerosis: combining physicians’ and patients’ perspectives? , 2011, Multiple sclerosis.

[145]  Kerina H. Jones,et al.  The feasibility of collecting information from people with Multiple Sclerosis for the UK MS Register via a web portal: characterising a cohort of people with MS , 2012, BMC Medical Informatics and Decision Making.

[146]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.

[147]  R. Benedict,et al.  Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis , 2003, Multiple sclerosis.

[148]  R. Motl,et al.  The effect of walking mobility on the measurement of physical activity using accelerometry in multiple sclerosis , 2009, Clinical rehabilitation.

[149]  Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. , 2001 .

[150]  Tjalf Ziemssen,et al.  Symptom management in patients with multiple sclerosis , 2011, Journal of the Neurological Sciences.

[151]  Alessandra Solari,et al.  The multiple sclerosis functional composite: different practice effects in the three test components , 2005, Journal of the Neurological Sciences.

[152]  A. Spaepen,et al.  Inter-rater reliability of the Ashworth scale in multiple sclerosis , 1994 .

[153]  J. Farrar,et al.  Validity, reliability, and clinical importance of change in a 0-10 numeric rating scale measure of spasticity: a post hoc analysis of a randomized, double-blind, placebo-controlled trial. , 2008, Clinical therapeutics.

[154]  Julián Benito-León,et al.  A review about the impact of multiple sclerosis on health-related quality of life , 2003, Disability and rehabilitation.

[155]  P. Rabins,et al.  Emotional disturbance in multiple sclerosis patients: validity of the General Health Questionnaire (GHQ) , 1981, Psychological Medicine.

[156]  J. Hobart,et al.  Measuring quality of life in multiple sclerosis: not as simple as it sounds , 2005, Multiple sclerosis.

[157]  A. Thompson,et al.  Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. , 2004, Health technology assessment.

[158]  A. Thompson,et al.  How responsive is the Multiple Sclerosis Impact Scale (MSIS-29)? A comparison with some other self report scales , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[159]  E. Kerckhofs,et al.  Evaluation of the Modified Fatigue Impact Scale in four different European countries , 2005, Multiple sclerosis.

[160]  J. Fisk,et al.  A comparison of health utility measures for the evaluation of multiple sclerosis treatments , 2004, Journal of Neurology, Neurosurgery & Psychiatry.

[161]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[162]  J. Hobart,et al.  Kurtzke scales revisited: the application of psychometric methods to clinical intuition. , 2000, Brain : a journal of neurology.

[163]  E. Mowry,et al.  Outcome Measures in Multiple Sclerosis , 2014, Multiple sclerosis international.